← back to search

Shuang Yu

Heilongjiang University of Chinese Medicine · CN
Area of research
Endocrinology, Diabetes and Metabolism · Cancer Research
Research interest
Research interests include Thyroid Cancer Diagnosis and Treatment, MicroRNA in disease regulation, Psoriasis: Treatment and Pathogenesis, and Ferroptosis and cancer prognosis.
h-index
43
citations
8,605
works
177
NIH funding
primary concept
email

Recent publications

Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Science 2025cited by 18position: middledoi
DDX17-Mediated Upregulation of CXCL8 Promotes Hepatocellular Carcinoma Progression <i>via</i> Co-activating β-catenin/NF-κB Complex
International Journal of Biological Sciences 2025cited by 6position: middledoi
New pathogen for gastric cancer: Streptococcus anginosus.
2024cited by 1position: contributordoi
H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.
2023cited by 58position: contributordoi
The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
2023cited by 57position: contributordoi
Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways
Thyroid 2023cited by 34position: middledoi
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
Oncogene 2022cited by 46position: middledoi
Tissue remodeling by an opportunistic pathogen triggers allergic inflammation
Immunity 2022cited by 42position: middledoi
Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study.
2021cited by 6position: contributordoi
Long-Term Programming of CD8 T Cell Immunity by Perinatal Exposure to Glucocorticoids
Cell 2020cited by 74position: middledoi
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Cell 2019cited by 499position: middledoi
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
Journal of Diabetes Research 2019cited by 70position: middledoi
Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice
Proceedings of the National Academy of Sciences 2019cited by 69position: middledoi
<i>MiR-195</i>Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting<i>CCND1</i>and<i>FGF2</i>
International Journal of Endocrinology 2017cited by 90position: middledoi
Apigenin attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defense
In Vitro Cellular & Developmental Biology - Animal 2017cited by 69position: middledoi
Amelioration of streptozotocin‑induced pancreatic β cell damage by morin: Involvement of the AMPK‑FOXO3‑catalase signaling pathway
International Journal of Molecular Medicine 2017cited by 28position: middledoi
Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation
Cell 2016cited by 588position: middledoi
Integrated Innate Mechanisms Involved in Airway Allergic Inflammation to the Serine Protease Subtilisin
The Journal of Immunology 2015cited by 41position: middledoi
Signaling through the Adaptor Molecule MyD88 in CD4+ T Cells Is Required to Overcome Suppression by Regulatory T Cells
Immunity 2014cited by 119position: middledoi
Signaling pathways activated by a protease allergen in basophils
Proceedings of the National Academy of Sciences 2014cited by 39position: middledoi
Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection
Science 2013cited by 292position: middledoi
Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity
Immunity 2013cited by 213position: middledoi
Circulating MicroRNA Profiles as Potential Biomarkers for Diagnosis of Papillary Thyroid Carcinoma
The Journal of Clinical Endocrinology & Metabolism 2012cited by 208position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ruslan Medzhitov · Yale University11 papers (2013–2025)Haipeng Xiao · Sun Yat-sen University5 papers (2012–2023) · 4 papers (2021–2024)Quan Zhang · Sun Yat-sen University3 papers (2012–2022)Andrew Wang · University of California, Santa Barbara3 papers (2016–2019)Cuiling Zhang · Guizhou University3 papers (2016–2019)Yanbing Li · Sun Yat-sen University3 papers (2012–2023)Mengting Qin · Jiangsu University2 papers (2017–2017)Shihua Shi · Chengdu University of Traditional Chinese Medicine2 papers (2023–2023)Bonan Chen · Chinese University of Hong Kong2 papers (2023–2023)Wei Kang · Kai Biotech (South Korea)2 papers (2023–2023)William Ka Kei Wu · Western Sydney University2 papers (2023–2023)Rachel K. Rosenstein · Hackensack University Medical Center2 papers (2013–2014)Bharat Vaidyanathan · Ono Pharmaceutical (United States)2 papers (2020–2022)Weiming Lv · Nanjing Agricultural University2 papers (2022–2023)Esther Borges Florsheim · Arizona State University2 papers (2013–2015)Harding H. Luan · Dolby (United States)2 papers (2016–2019)Lesley Pasman · Harvard University2 papers (2013–2014)Carmen J. Booth · Yale University2 papers (2016–2019)Scott D. Pope · Howard Hughes Medical Institute2 papers (2019–2025)